Skip to main content

What the FDA labels say about taking them together

Cobicistat and magnesium hydroxide

Cobicistat's FDA label of February 10, 2026 names magnesium hydroxide in its drug interactions section; the magnesium hydroxide label PlainMeds reads does not name cobicistat.

Check it at the source: the cobicistat FDA label on DailyMed (effective February 10, 2026, Gilead Sciences, Inc.); the magnesium hydroxide FDA label on DailyMed (effective August 21, 2026).

What does the cobicistat label say about magnesium hydroxide?

Cobicistat label, drug interactions

Concomitant Drug Class/Drug Name: Antacids: e.g., aluminum and magnesium hydroxide (please also see and below); Potential Effect ↑ = Increase, ↓ = Decrease, ↔ = No change: ↓ atazanavir; Clinical Comment: TYBOST coadministered with atazanavir: With concomitant use, administer a minimum of 2 hours apart.

Source: FDA drug label (Tybost), Gilead Sciences, Inc., effective February 10, 2026 (SPL set 3784c35c-e87f-410c-900b-8fd6313c6010), via openFDA; the full label on DailyMed

What does the magnesium hydroxide label say about cobicistat?

Magnesium hydroxide's label (effective August 21, 2026) does not name cobicistat in these sections. A label lists what its studies and reports found; it is not a complete list.

Source: FDA drug label (MiraFAST soft chews), Bayer HealthCare LLC., effective August 21, 2026 (SPL set 2cee67dd-b71f-32b8-e063-6394a90ae864), via openFDA; the full label on DailyMed

These are the labels' own sentences. PlainMeds does not grade interactions; a pharmacist or prescriber can say what they mean for one person's medicines.

Both medicines on the record

0Cobicistat generic labelers
0Magnesium hydroxide generic labelers
CobicistatMagnesium hydroxide
Labeled forHIVConstipation, Acid reflux and ulcers
Boxed warningNoNo
Pharmacy cost (NADAC)n/a$0.0095 per mL Milk of magnesia suspension
Shortage nowA presentation being discontinuedNo current entry

Source: FDA NDC Directory, CMS NADAC of October 7, 2026 and the FDA Drug Shortage Database (FDA files October 8, 2026)

What next?